Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 14, 2011; 17(22): 2723-2733
Published online Jun 14, 2011. doi: 10.3748/wjg.v17.i22.2723
Published online Jun 14, 2011. doi: 10.3748/wjg.v17.i22.2723
Extraintestinal manifestations | Adverse effects of treatments | Comorbid conditions | Direct consequences of the disease |
Peripheral and axial arthritis | Steroids: cataracts, glaucoma, mood changes, osteoporosis… | Cardiovascular | Abdominal and retroperitoneal scarring: hydronephrosis, intestinal obstruction, female infecundity… |
Erythema nodosum, pyoderma gangrenosum, oral aphtae | Immunosuppressors: infections, neoplasia, liver toxicity, myelosuppression… | Hepatic, biliary, pancreatic, digestive | Consequences of intestinal resection: malabsorption, short bowel syndrome, oxalate nephrolithiasis |
Uveitis, episcleritis, blepharitis | Biologics: infections, neoplasia, demyelinizing disease, infusion | Metabolic: obesity | Persistent inflammation: osteoporosis, amyloidosis |
Primary sclerosing cholangitis | Reactions, drug-induced lupus | Neuropsychiatric |
- Citation: Román ALS, Muñoz F. Comorbidity in inflammatory bowel disease. World J Gastroenterol 2011; 17(22): 2723-2733
- URL: https://www.wjgnet.com/1007-9327/full/v17/i22/2723.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i22.2723